ISSN 1662-4009 (online)

ESPE Yearbook of Paediatric Endocrinology (2023) 20 6 | DOI: 10.1530/ey.20.6
0
Err

1Department of Women’s and Children’s Health, Pediatric Endocrinology Unit; Karolinska University Hospital/Karolinska Institutet, 171 76 Stockholm, Sweeden; 2Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Athens, 11527, Greece; 3Division of Endocrinology and Metabolism, Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, Athens, 11527, Greece.
*Equal author contribution.
Evangelia Charmandari, MD, MSc, PhD, MRCP(UK), CCST(UK), Professor of Pediatric and Adolescent Endocrinology, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, ‘Aghia Sophia’ Children’s Hospital, Thivon and Papadiamantopoulou Street, Athens, 11527, Greece; Tel/Fax: +30-213-2013 384


For this year’s chapter on ‘Adrenals’, we have searched the PubMed for articles on ‘adrenal’ or ‘steroidogenesis’ published in English between June 1, 2022 and May 31, 2023. Our search yielded more than 6,000 citations. We have examined all citations individually and selected the following collection of basic research and clinical articles. Whenever possible, we have avoided topics that have been discussed in the Yearbook 2022, unless progress in the field has been incremental. Emerging themes for this year’s chapter include: i) Loss of SUMO-specific protease 2 causes isolated glucocorticoid deficiency by blocking adrenal cortex zonal transdifferentiation in mice; ii) Circadian regulation of hippocampal function is disrupted with corticosteroid treatment; iii) Leukocyte telomere length is reduced in children with Congenital Adrenal Hyperplasia; iv) Metabotypes of CAH determined by gas chromatography-mass spectrometry in spot urine; v) A polygenic risk score helps discriminate primary adrenal insufficiency of different etiologies; vi) Crinecerfont, a CRF1 Receptor Antagonist, lowers adrenal androgens in adolescents with Congenital Adrenal Hyperplasia.

Article tools

My recent searches

No recent searches.

My recently viewed abstracts

Adrenals (<1 min ago)